After years of trials with monkeys, Elon Musk’s brain-computer interface start-up Neuralink Corp., says it’s now looking for human volunteers to take part in a new set of trials. Musk’s company ...

China's NMPA granted Neuracle Medical Technology the world's first commercial approval for an invasive brain-computer ...

The pharmaceutical and medical device industries stand at an inflection point. After decades of reliance on traditional randomized controlled trials (RCTs), computational modeling and simulation (CM&S ...

Elon Musk has his hands quite full with various businesses including X (Twitter), Tesla, SpaceX, and Neuralink. The latter of which has been steadily developing its brain-computer interface (BCI) in ...

In a remarkable leap forward for neuroscience and technological innovation, Elon Musk's brain implant company Neuralink has officially received approval from the FDA to begin the first human trials of ...

Turns out Elon Musk's FDA prediction was only off by about a month. After reportedly denying the company's overtures in March, the FDA approved Neuralink's application to begin human trials of its ...

The study will take six years and is looking for people with quadriplegia to test the whole Neuralink system. The study will take six years and is looking for people with quadriplegia to test the ...

Add Popular Science (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

"Progress is good, and the patient seems to have made a full recovery, with no ill effects that we are aware of. The patient can move a mouse around the screen by just thinking. "Elon Musk said in a ...

A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...